13.59
price up icon3.27%   0.43
after-market Handel nachbörslich: 13.59
loading

Finanzdaten der Kalvista Pharmaceuticals Inc-Aktie (KALV)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
28.16%
55.03
42.94 45.81 44.22 48.45
Operating Income/Loss
28.16%
-55.03
-42.94 -45.81 -44.22 -48.45
Nonoperating Income/Loss
247.43%
1.949
-1.322 3.543 3.772 3.806
Income/Loss From Continuing Operations Before Tax
19.92%
-53.08
-44.26 -42.27 -40.44 -44.65
Income Tax Expense/Benefit
120.13%
-0.855
4.247 - - -
Income/Loss From Continuing Operations After Tax
7.66%
-52.23
-48.51 -42.27 -40.44 -44.65
Net Income/Loss
7.66%
-52.23
-48.51 -42.27 -40.44 -44.65
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
97.85%
1.1305
52.64 46.70 46.23 2.2187
Diluted Average Shares
97.85%
1.1305
52.64 46.70 46.23 2.2187
Basic Earnings Per Share
7.61%
-0.99
-0.92 -0.91 -0.87 -1.07
Diluted Earnings Per Share
7.61%
-0.99
-0.92 -0.91 -0.87 -1.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):